Literature DB >> 28722319

Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients.

S D Jalal1, N A S Al-Allawi2, A A S Al Doski2.   

Abstract

INTRODUCTION: The identification of aberrancies in leukemia-associated immunophenotype (LAIP) of acute lymphoblastic leukemia (ALL) is quite important in the assessment of minimal residual disease (MRD). This study, the first from Iraq, aimed to assess the frequency and patterns of LAIP among Iraqi patients with ALL, to establish future strategies for evaluating MRD.
METHODS: A total of 282 newly diagnosed Iraqi ALL cases were analyzed with six-parameter flow cytometry using a panel of 29 monoclonal antibodies.
RESULTS: Immunological subtyping revealed that 85.5% of cases were B-ALL and the remainder T-ALL. LAIP was detected in 97.1% of B-ALL, and in 26.8% of T-ALL. The asynchronous maturation-associated antigen patterns in B-ALL were CD10strong+ /TdTdim+ , CD38dim+ /CD34+ , CD10dim+ /CD34+ , CD10strong /CD20strong+ , CD20strong+ /CD34+, and CD45dim+ /CD20strong+ in 84.6%, while the cross-lineage myeloid expression was seen in 81.3% and aberrant T-cell antigen expression in 6.2%. For T-ALL, asynchronous maturation-associated antigen patterns included the following: CD1a+ /CD5+ /sCD3+ and CD34+ /sCD3+ in 12.2%. Myeloid and B-cell antigen expression were each identified in 7.3% of T-ALL. No significant differences in LAIP were found between children and adults.
CONCLUSION: The high rates and the patterns of LAIP particularly in Iraqi B-ALL patients may allow the development of more cost-effective strategies for MRD monitoring.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  acute leukemia; acute lymphoblastic leukemia; flow cytometry; immunophenotyping; minimal residual disease

Mesh:

Substances:

Year:  2017        PMID: 28722319     DOI: 10.1111/ijlh.12716

Source DB:  PubMed          Journal:  Int J Lab Hematol        ISSN: 1751-5521            Impact factor:   2.877


  4 in total

1.  Immunophenotypic characteristics of T lineage acute lymphoblastic leukemia: absence of immaturity markers-TdT, CD34 and HLADR is not uncommon.

Authors:  Richa Gupta; Neha Garg; Mrinalini Kotru; Dilip Kumar; Rajesh Pathak
Journal:  Am J Blood Res       Date:  2022-02-15

2.  The Outcome of Acute Lymphoblastic Leukemia in 109 Adult Iraqi Patients.

Authors:  Dyna Jaza Mohammed; Sana Dlawar Jalal; Ahmed Khudair Yassin; Ali Ibrahim Mohammed; Nasir Abdulsalam Al-Allawi
Journal:  Indian J Hematol Blood Transfus       Date:  2020-09-03       Impact factor: 0.900

3.  CD34 is not Expressed by Blasts in a Third of B-ALL Patients and its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis.

Authors:  Neha Garg; Richa Gupta; Mrinalini Kotru
Journal:  Asian Pac J Cancer Prev       Date:  2021-03-01

4.  Approach to the Adult Acute Lymphoblastic Leukemia Patient.

Authors:  Valentina Sas; Vlad Moisoiu; Patric Teodorescu; Sebastian Tranca; Laura Pop; Sabina Iluta; Sergiu Pasca; Cristina Blag; Sorin Man; Andrei Roman; Catalin Constantinescu; Ioana Rus; Mihail Buse; Bogdan Fetica; Mirela Marian; Cristina Selicean; Ioana Berindan-Neagoe; Bobe Petrushev; Horia Bumbea; Alina Tanase; Mihnea Zdrenghea; Shigeo Fuji; Shigehisa Kitano; Ciprian Tomuleasa
Journal:  J Clin Med       Date:  2019-08-06       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.